Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
Sickle cell disease is a life-threatening haematological condition described as the most neglected global health problem today. There are enough data to show the enormous health, economic, and social cost of sickle cell disease worldwide, and yet, the condition remains a low priority in the agenda of governments, and the haematology and global health communities. There is also enough evidence on simple, effective interventions that could substantially improve the lives of people with sickle cell disease,
